Is it time to recommend cardiovascular protection for all?
- PMID: 38165051
- DOI: 10.1097/HJH.0000000000003501
Is it time to recommend cardiovascular protection for all?
References
-
- Kannel WB, Gordan T. Evaluation of cardiovascular risk in the elderly: the Framingham Study. Bull N Y Acad Med 1978; 54:573–591.
-
- Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:b1665.
-
- Wright JT, Williamson JD, Whelton PK, Snyder JK, Sink KM, et al. SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med 2015; 373:2103–2116.
-
- Zhang W, Zhang S, Deng Y, Wu S, Ren J, Sun G, et al. STEP Study Group. Trial of intensive blood-pressure control in older patients with hypertension. N Engl J Med 2021; 383:1268–1279.
-
- Cushman WC, Evans GW, Byington RP, Goff DC Jr, Grimm RH Jr, Cutler JA, et al. ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1575–1585.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources